These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically. Imafuku A, Nozu K, Sawa N, Hasegawa E, Hiramatsu R, Kawada M, Hoshino J, Tanaka K, Ishii Y, Takaichi K, Fujii T, Ohashi K, Iijima K, Ubara Y. Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582 [Abstract] [Full Text] [Related]
3. Thin basement membrane nephropathy. Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY. Kidney Int; 2003 Oct; 64(4):1169-78. PubMed ID: 12969134 [Abstract] [Full Text] [Related]
10. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains]. Heidet L, Gubler MC. Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395 [Abstract] [Full Text] [Related]
11. Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis. Papazachariou L, Papagregoriou G, Hadjipanagi D, Demosthenous P, Voskarides K, Koutsofti C, Stylianou K, Ioannou P, Xydakis D, Tzanakis I, Papadaki A, Kallivretakis N, Nikolakakis N, Perysinaki G, Gale DP, Diamantopoulos A, Goudas P, Goumenos D, Soloukides A, Boletis I, Melexopoulou C, Georgaki E, Frysira E, Komianou F, Grekas D, Paliouras C, Alivanis P, Vergoulas G, Pierides A, Daphnis E, Deltas C. Clin Genet; 2017 Nov; 92(5):517-527. PubMed ID: 28632965 [Abstract] [Full Text] [Related]
12. Spectrum of collagen type IV nephropathies: from thin basement membrane nephropathy to Alport syndrome. Vizjak A, Ferluga D. Srp Arh Celok Lek; 2008 Dec; 136 Suppl 4():323-6. PubMed ID: 20804103 [Abstract] [Full Text] [Related]
15. Chronic renal failure and shortened lifespan in COL4A3+/- mice: an animal model for thin basement membrane nephropathy. Beirowski B, Weber M, Gross O. J Am Soc Nephrol; 2006 Jul; 17(7):1986-94. PubMed ID: 16775036 [Abstract] [Full Text] [Related]
16. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome. Kamiyoshi N, Nozu K, Fu XJ, Morisada N, Nozu Y, Ye MJ, Imafuku A, Miura K, Yamamura T, Minamikawa S, Shono A, Ninchoji T, Morioka I, Nakanishi K, Yoshikawa N, Kaito H, Iijima K. Clin J Am Soc Nephrol; 2016 Aug 08; 11(8):1441-1449. PubMed ID: 27281700 [Abstract] [Full Text] [Related]
17. Three Novel Heterozygous COL4A4 Mutations Result in Three Different Collagen Type IV Kidney Disease Phenotypes. Li A, Gao EZ, Cui YX, Liu JH, Lv X, Wei XX, Xia XY, Gao CL, Liu FX, Xia ZK, Asan, Liu ZH, Li XJ. Cytogenet Genome Res; 2018 Aug 08; 154(1):30-36. PubMed ID: 29669314 [Abstract] [Full Text] [Related]
19. How to resolve confusion in the clinical setting for the diagnosis of heterozygous COL4A3 or COL4A4 gene variants? Discussion and suggestions from nephrologists. Imafuku A, Nozu K, Sawa N, Nakanishi K, Ubara Y. Clin Exp Nephrol; 2020 Aug 08; 24(8):651-656. PubMed ID: 32232700 [Abstract] [Full Text] [Related]